Brind.
  1. Amylyx Pharmaceuticals received FDA Fast Track designation on August 7, 2025, for treatments aimed at ALS, including evaluating avexitide post-RYGB surgery.

Avexitide received FDA Breakthrough Therapy designation.

5 reports, 3 independent Updated Aug 18
Gone quiet Reached 3 outlets in its first 24 hours
Reports
5
Developments
3
Repetition
60%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

Avexitide received FDA Breakthrough Therapy designation.

Who's involved

What this event is mainly about
Amylyx PharmaceuticalsFDA

How it developed

Newest first. Tap a step to see who reported it.
  1. Amylyx Pharmaceuticals is seeking FDA approval for a new drug treatment.Sub-event
  2. Avexitide received Breakthrough Therapy designation from the FDA.1 source
  3. FDA set the primary endpoint for avexitide trials on July 14, 2025.1 source

Keep exploring

Part of

Amylyx Pharmaceuticals received FDA Fast Track designation on August 7, 2025, for treatments aimed at ALS, including evaluating avexitide post-RYGB surgery. All 2 developments

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • Insider MonkeyAmylyx Pharmaceuticals Shares Promising Avexitide Data for Post-Bariatric Hypoglycemia at ENDO 2025, Phase 3 Enrollment Nears Completion Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is one of the best l
  • Clinical Trials ArenaAmylyx presents new exploratory analyses from avexitide trials for PBH Amylyx Pharmaceuticals has presented new exploratory analyses from the Phase II PREVENT and Phase IIb trials of the investigatio
  • Business WireAmylyx Pharmaceuticals Presents New Exploratory Analyses from Phase 2 and Phase 2b Clinical Trials of Avexitide in Post-Bariatric Hypoglycemia at ENDO 2025 - Pivotal Phase 3 LUCIDITY trial of avexiti
  • Unknown outlet
1 more outlet ran the same wire story